AGE Centrum s.r.o.

The AGE Centrum s.r.o. site in Olomouc is conducting clinical research in nervous system diseases and mental disorders, with a strong focus on Alzheimer’s disease and related cognitive and behavioral symptoms. These studies are designed to evaluate new approaches for improving memory, thinking, function, and agitation control in people living with mild cognitive impairment, mild to moderate Alzheimer’s disease, and agitation associated with Alzheimer’s disease.

• Testing therapies aimed at improving cognition and daily function in early Alzheimer’s disease
• Evaluating treatments for agitation and behavioral symptoms linked to Alzheimer’s disease
• Studying options for people with biomarker evidence of inflammation in early neurodegenerative disease

Overall, this research area combines symptom management with efforts to slow or improve disease-related decline, offering potential benefit for both patients and caregivers.

Clinical trials at AGE Centrum s.r.o. also cover immune system diseases and skin and connective tissue diseases, especially atopic dermatitis. The studies are centered on reducing inflammation, improving skin symptoms, and maintaining treatment response over time in people with moderate-to-severe disease.

• Assessing long-term safety and effectiveness of new therapies for atopic dermatitis
• Comparing active treatment with placebo to better understand symptom control
• Exploring ways to maintain response after initial improvement in chronic skin inflammation

This research supports the development of better options for people whose skin disease remains difficult to control with standard care.

The site is involved in musculoskeletal diseases research, with a clear emphasis on rheumatoid arthritis. These trials are focused on easing joint inflammation, improving disease activity, and finding more effective treatment strategies for people who have not responded well to prior therapies or who are newly diagnosed.

• Evaluating new anti-inflammatory treatments for moderate to severe rheumatoid arthritis
• Studying treatment combinations for early disease control in newly diagnosed patients
• Comparing investigational approaches with placebo or standard therapy to measure symptom improvement

By addressing both early and more established disease, this research aims to refine care for patients living with chronic inflammatory joint conditions.

Research at AGE Centrum s.r.o. includes digestive system diseases, particularly ulcerative colitis. The trial activity in this area is centered on achieving clinical remission and improving control of intestinal inflammation in people with active disease.

• Assessing whether treatment can help patients reach remission more effectively
• Measuring improvement in bowel symptoms and endoscopic signs of inflammation
• Supporting the search for better options for patients with persistent inflammatory bowel disease

This work reflects an ongoing effort to improve both symptom relief and disease control in chronic gastrointestinal inflammation.